The Market Reports

SynopsisApomorphine is a non-selective dopamine agonist which activates both D2-like and, to a much lesser extent, D1-like receptors. It also acts as an antagonist of 5-HT2 and α-adrenergic receptors with high affinity. The compound is historically a morphine decompos.....

SynopsisThe global Portable Sphygmomanometers market was valued at US$ 975 million in 2023 and is anticipated to reach US$ 1394.1 million by 2030, witnessing a CAGR of 5.3% during the forecast period 2024-2030. According to our research, the global market for me.....

SynopsisThe roots of artificial breathing can be traced back to World War II when pilots faced challenges in breathing at high altitudes. Similarly, in places where oxygen content is low or during underwater dives, artificial breathing is used to facilitate adequate o.....

SynopsisEnoxolone is a pentacyclic triterpenoid derivative of the beta-amyrin type obtained from the hydrolysis of glycyrrhizic acid. Enoxolone is a type of anti-inflammatory agent. The global Enoxolone market was valued at US$ XX million in 2020 an.....

SynopsisThis report on the plasma protease C1-inhibitors treatment market analyzes the current and future scenario of the global market. Large number of acute HAE patients is increasing the usage of plasma protease C1-inhibitors treatment. Increasing prevalence of rar.....

SynopsisDydrogesterone is a progestin medication, which used for a variety of indications, including threatened or recurrent miscarriage during pregnancy, dysfunctional bleeding, infertility due to luteal insufficiency, dysmenorrhea, endometriosis, secondary amenorrhe.....

SynopsisGlobal Bromfenac Sodium API market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led.....

SynopsisThe global Deoxygenation System market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimati.....

SynopsisThe global GnRH Agonist market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. GnRH, also known as gonadotropin-releasing hormone, is a peptide hormone secreted by.....

Synopsis Demyelinating disease is a kind of nervous system disease, in which the main or initial lesion is demyelination, and the damage of axon, cell body and glia is relatively minor. It can occur in the central nervous system or the peripheral nervous.....